Agatolimod Sodium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Agatolimod Sodium, covering 2014-09-01 to 2014-09-01. Get the full timeline:
Most recent: Clinical Trial Update: Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]